ImageneBio Statistics
Total Valuation
ImageneBio has a market cap or net worth of $182.70 million. The enterprise value is $185.86 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ImageneBio has 11.60 million shares outstanding.
| Current Share Class | 11.60M |
| Shares Outstanding | 11.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 10.79% |
| Float | 10.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 42.49 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 43.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35
| Current Ratio | 0.35 |
| Quick Ratio | 0.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -174.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 280.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ImageneBio has paid $13,000 in taxes.
| Income Tax | 13,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -19.48% |
| 50-Day Moving Average | 16.08 |
| 200-Day Moving Average | 17.07 |
| Relative Strength Index (RSI) | 47.39 |
| Average Volume (20 Days) | 47,938 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ImageneBio had revenue of $4.30 million and -$32.35 million in losses. Loss per share was -$0.08.
| Revenue | 4.30M |
| Gross Profit | 4.30M |
| Operating Income | -20.56M |
| Pretax Income | n/a |
| Net Income | -32.35M |
| EBITDA | -20.02M |
| EBIT | -20.56M |
| Loss Per Share | -$0.08 |
Balance Sheet
The company has $4.92 million in cash and $8.08 million in debt, giving a net cash position of -$3.16 million or -$0.27 per share.
| Cash & Cash Equivalents | 4.92M |
| Total Debt | 8.08M |
| Net Cash | -3.16M |
| Net Cash Per Share | -$0.27 |
| Equity (Book Value) | -7.51M |
| Book Value Per Share | -0.41 |
| Working Capital | -13.03M |
Cash Flow
| Operating Cash Flow | -19.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -478.09% |
| Pretax Margin | -472.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImageneBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -17.70% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ImageneBio has an Altman Z-Score of -26.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.69 |
| Piotroski F-Score | 1 |
